System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Gregory C Gray is an expert in Infectiology at The University of Texas Medical Branch at Galveston (United States). Gregory C Gray has authored 408 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 1 of them ongoing. SLR score: 1,539 (community average: 125). How the SLR is computed.

LeadR Profile

Gregory C Gray The University of Texas Medical Branch at Galveston United States
1 539 ScienceLeadR Reputation 1539

Unlock

Register Login
Network Map

Infectiology

Subspecialties: Pulmonology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1994 - 2026
Source: PubMed

The University of Texas Medical Branch at Galveston

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 408

Citations

Citations: 18 625 1st author: 58 Last author: 195 Unique author: 6

Main journals

Clin Infect Dis 32
Influenza Other Respir Viruses 24
Emerg Infect Dis 23
Mil Med 16
PLoS One 15

Best Journals

N Engl J Med 3
JAMA 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Detection of antibodies to avian influenza virus H5N1 clade 2.3.4.4b in naturally infected cattle for more than a year.
PMID 42209625 — antibodies, influenza a virus, h5n1 subtype, farms, influenza in birds, influenza, human, viruses, immunity, orthomyxoviridae, infections		Sci Rep20260
Detection and Genomic Characterization of Novel Respiratory Viruses in US and Mexican Cattle Farms.
PMID 42137610 — coronavirus, coronavirus, bovine, farms, animal diseases, veterinary medicine, herpesvirus 1, cercopithecine, metagenomics, influenza, human, zoonoses, viruses, rhinitis, environment		Transbound Emerg Dis20260
Why We Must Vaccinate US Dairy Cattle Against HPAI H5N1.
PMID 41856169 — vaccines, public health, food security, communicable diseases, economics		J Infect Dis20260
Emerging Respiratory Virus Threats from Influenza D and Canine Coronavirus HuPn-2018.
PMID 41564895 — coronavirus, communicable disease control, coronavirus, canine, respiratory tract infections, influenza, human, zoonoses, viruses		Emerg Infect Dis20260
MAJOR LIVESTOCK-ASSOCIATED ZOONOSES IN MONGOLIA: AN OVERVIEW.
PMID 41551725 — epidemiology, public health, zoonoses		Zoonoses20250

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 3
Phase 2 1
Phase 4 1

By status:

Completed 4
Recruiting 1

By type:

Observational 3
Interventional 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 2
multicentric5to9 1
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 26

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
BPL 1357 Against H1N1 Influenza Virus Challenge
NCT07215858 — safety, blood, vaccines, influenza, human, viruses, nasal sprays, nose, orthomyxoviridae		Phase 2Recruiting2026

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS